Balchem Corporation (BCPC)

About Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

As of November 3, 2026, Balchem Corporation (BCPC) stock edged higher to $175.04, up 0.25% (+$0.44) versus the previous close. On the day, shares have traded between $172.56 and $175.32. That puts BCPC in the upper third of its 52-week range of $147.18 to $183.90. Balchem Corporation operates in the chemicals & allied products space and carries a market capitalization of roughly $5.42 billion, with about 31.8K shares changing hands.

Latest BCPC news

• Balchem Corporation to Participate in Baird’s Global Industrial Conference on November 11, 2026Yahoo Finance· Oct 28, 7:00 AM ET
• 3 Companies With Room to Pass on Costs to Manage Inflationmarketbeat.com· Oct 26, 11:30 AM ET
• Balchem (BCPC) Stock Can Q3 Earnings Spark A Bigger Rerating?Yahoo Finance· Oct 25, 5:11 AM ET
• Balchem Corporation Q3 2026 Earnings Call Summaryapp.moby.co· Oct 24, 8:30 AM ET
• Balchem: 3 Key Takeaways for Long-Term Investorsfool.com· Oct 23, 2:32 PM ET
• Balchem (BCPC) Q3 2026 Earnings Call Transcriptfool.com· Oct 23, 2:13 PM ET
• Balchem Corporation Reports Third Quarter 2026 Financial ResultsYahoo Finance· Oct 23, 7:00 AM ET
• Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2026 Financial Results on October 23, 2026Yahoo Finance· Oct 9, 7:00 AM ETET

Source: Yahoo Finance RSS · Updated November 3, 2026

Want BCPC headlines, alerts and AI research in one place? Create a free account →

• New research on @BalchemCorp $BCPC #sidotiresearch Read note: http://dlvr.it/TW90wc #investing #smallcap #microcap

  @Sidoti· Nov 2, 2:48 PM ET

• $BCPC Balchem's record Q3 held a $4.0M legal gain, partly offset by a $1.9M impairment, as Human Nutrition & Health prices fell 4.4%. 🏢 Balchem, a nutrition ingredients and specialty products maker worth about $5.56B at $174.325 at 10:31 ET on October 26, 2026, said i…

  @filecrux· Oct 26, 10:35 AM ET

• https://www.marketbeat.com/earnings/reports/2026-10-23-balchem-co-stock/ $BCPC Balchem Earnings Transcript

  @EarningsInsider· Oct 23, 12:01 PM ET

• $BCPC Balchem Q3 sales hit a record 290.7 million dollars, up 8.6%, and adjusted EPS was 1.57 dollars vs 1.43 dollars expected (MarketBeat). All three segments grew. Human nutrition was still the engine, record sales of 188.2 million dollars, up 8.1%, with segment earnings up …

  @KryptonResearch14· Oct 23, 9:31 AM ET

• $BCPC Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $1.57 up 16.30% YoY • Reported revenue of $290.66M up 8.63% YoY

  @StocktwitsEarnings· Oct 23, 7:29 AM ET

Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →